Dyne Therapeutics, Inc. (DYN) is listed on NASDAQ in Pharmaceutical Stocks. It is $25.07, -3.91%, with a $4.7B market cap. RSI is 48.2, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 48.2 Neutral
Market Cap $4.7B
Volume 850.3K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-299.4M
EPS $-1.81
Debt / Equity 0.3x
P/E Ratio -13.9x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Rhodes Jason P | Insider | Sell | 2,586,928 | $25.20 | $65.2M | 2026 Aug 14 |
| Friedl-naderer Johanna | Chief Commercial Officer | Sell | 226 | $26.28 | $5,939 | 2026 Aug 13 |
| Kerr Douglas | Chief Medical Officer | Sell | 1,556 | $26.28 | $40,892 | 2026 Aug 13 |
| Cox John | CEO & President | Sell | 4,986 | $26.28 | $131,032 | 2026 Aug 13 |
| Lucera Erick | Chief Financial Officer | Sell | 1,797 | $26.28 | $47,225 | 2026 Aug 13 |
| Kersten Dirk | Insider | Sell | 261,460 | $25.51 | $6.7M | 2026 Jul 27 |
| Rhodes Jason P | Insider | Sell | 777,451 | $22.97 | $17.9M | 2026 Jul 7 |
| Rhodes Jason P | Insider | Sell | 504,695 | $21.23 | $10.7M | 2026 Jun 29 |
| Lucera Erick | Chief Financial Officer | Sell | 2,362 | $20.37 | $48,114 | 2026 Jun 25 |
| Rhodes Jason P | Insider | Sell | 267,760 | $21.09 | $5.6M | 2026 Jun 25 |
| Kersten Dirk | Insider | Sell | 263,962 | $20.70 | $5.5M | 2026 Jun 23 |
| Kersten Dirk | Insider | Sell | 84,355 | $20.10 | $1.7M | 2026 Jun 18 |
| Kerr Douglas | Chief Medical Officer | Sell | 887 | $18.33 | $16,259 | 2026 Jun 16 |
| Friedl-naderer Johanna | Chief Commercial Officer | Sell | 145 | $18.33 | $2,658 | 2026 Jun 16 |
| Cox John | CEO & President | Sell | 2,683 | $18.33 | $49,179 | 2026 Jun 16 |
| Posner Brian S | Insider | Buy | 2,000 | $16.94 | $33,880 | 2026 Jun 8 |
| Posner Brian S | Insider | Buy | 2,500 | $17.48 | $43,700 | 2026 Jun 3 |
| Posner Brian S | Insider | Buy | 2,000 | $18.21 | $36,420 | 2026 May 26 |
| Posner Brian S | Insider | Buy | 2,500 | $17.12 | $42,800 | 2026 May 20 |
| Friedl-naderer Johanna | Chief Commercial Officer | Sell | 228 | $18.36 | $4,186 | 2026 May 13 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $29.12 | 56.8 | $5.0B |
Take DYN further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DYN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Dyne Therapeutics, Inc. next reports.
Set alerts on DYN
Get notified when Dyne Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free